ANXA6 and breast cancer: Furthermore, a study by Keklikoglou et al. showed that chemotherapy-induced EVs have higher levels of annexin A6 in breast cancer patients undergoing neoadjuvant chemotherapy as compared to the pre-treatment levels (30).